DANAHER CORP /DE/

Danaher Corporation is a global science and technology innovator with more than 15 operating companies in the biotechnology, life sciences, and diagnostics sectors. The company's business strategy includes strengthening its competitive advantage, enhancing its portfolio in attractive markets, and consistently attracting and retaining exceptional talent. Danaher's businesses are typically characterized by a high level of products and services sold on a recurring basis, primarily through a direct sales model and to a geographically diverse customer base. The company's business segments are Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes businesses that offer solutions for bioprocessing and discovery and medical applications. The Bioprocessing business provides technologies, consumables, services, and solutions for the development and manufacture of therapeutics, including protein-based and other biological therapies, as well as emerging classes of highly-targeted therapies. The Discovery and Medical business offers solutions for sample preparation, diagnostic assays, and healthcare filtration solutions. The Life Sciences segment offers instruments, consumables, services, and software for studying genomics and the basic building blocks of life, including DNA and RNA, nucleic acid, proteins, metabolites, and cells. The segment also provides products and consumables used to filter and remove contaminants from a variety of liquids and gases in many end-market applications. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The segment includes businesses that offer solutions for core lab-clinical testing, molecular diagnostics, acute care diagnostics, and pathology diagnostics. Danaher's website is www.danaher.com, and its ticker symbol is DHR.